Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fulvia Ceccarelli

Showing results (61-70 of 198) with videos related to

Pageof 20
Sort By:
Life (Basel, Switzerland)|April 28, 2023
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive StudyFulvia Ceccarelli, Francesco Natalucci, Licia Picciariello, et al.
The Journal of Rheumatology|December 1, 2007
Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritisAnnamaria Iagnocco, Emilio Filippucci, Chiara Perella, et al.
Lupus|March 6, 2023
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine <i>in vitro</i>Lucia Novelli, Cristiana Barbati, Cristina Capuano, et al.
Mediators of Inflammation|June 14, 2019
Periodontitis and Rheumatoid Arthritis: The Same Inflammatory Mediators?Fulvia Ceccarelli, Matteo Saccucci, Gabriele Di Carlo, et al.
Joint Bone Spine|October 16, 2021
Can machine learning models support physicians in systemic lupus erythematosus diagnosis? Results from a monocentric cohortFulvia Ceccarelli, Matteo Lapucci, Giulio Olivieri, et al.
BMC Musculoskeletal Disorders|April 19, 2015
Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up studyManuela Di Franco, Ilaria Barchetta, Cristina Iannuccelli, et al.
Clinical and Experimental Rheumatology|October 28, 2022
Erosive arthritis in systemic lupus erythematosus: application of cluster analysisFulvia Ceccarelli, Francesco Natalucci, Carmelo Pirone, et al.
Epigenomics|December 18, 2020
Altered expression of miR-142, miR-155, miR-499a and of their putative common target <i>MDM2</i> in systemic lupus erythematosusAndrea Latini, Cinzia Ciccacci, Giada De Benedittis, et al.
Genes|December 30, 2025
An <i>ETS2</i> Enhancer Variant May Modulate Gene Expression and Contribute to Defining a Genetic Risk Profile for SLE SusceptibilityAndrea Latini, Giada De Benedittis, Chiara Morgante, et al.
Immunologic Research|September 4, 2024
The dysregulation of mitochondrial homeostasis-related genes could be involved in the decrease of mtDNA copy number in systemic lupus erythematosus patientsGiada De Benedittis, Andrea Latini, Chiara Morgante, et al.
Pageof 20

Showing results (61-70 of 198) with videos related to

Sort By:
Pageof 20
Life (Basel, Switzerland)|April 28, 2023
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive StudyFulvia Ceccarelli, Francesco Natalucci, Licia Picciariello, et al.
The Journal of Rheumatology|December 1, 2007
Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritisAnnamaria Iagnocco, Emilio Filippucci, Chiara Perella, et al.
Lupus|March 6, 2023
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine <i>in vitro</i>Lucia Novelli, Cristiana Barbati, Cristina Capuano, et al.
Mediators of Inflammation|June 14, 2019
Periodontitis and Rheumatoid Arthritis: The Same Inflammatory Mediators?Fulvia Ceccarelli, Matteo Saccucci, Gabriele Di Carlo, et al.
Joint Bone Spine|October 16, 2021
Can machine learning models support physicians in systemic lupus erythematosus diagnosis? Results from a monocentric cohortFulvia Ceccarelli, Matteo Lapucci, Giulio Olivieri, et al.
BMC Musculoskeletal Disorders|April 19, 2015
Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up studyManuela Di Franco, Ilaria Barchetta, Cristina Iannuccelli, et al.
Clinical and Experimental Rheumatology|October 28, 2022
Erosive arthritis in systemic lupus erythematosus: application of cluster analysisFulvia Ceccarelli, Francesco Natalucci, Carmelo Pirone, et al.
Epigenomics|December 18, 2020
Altered expression of miR-142, miR-155, miR-499a and of their putative common target <i>MDM2</i> in systemic lupus erythematosusAndrea Latini, Cinzia Ciccacci, Giada De Benedittis, et al.
Genes|December 30, 2025
An <i>ETS2</i> Enhancer Variant May Modulate Gene Expression and Contribute to Defining a Genetic Risk Profile for SLE SusceptibilityAndrea Latini, Giada De Benedittis, Chiara Morgante, et al.
Immunologic Research|September 4, 2024
The dysregulation of mitochondrial homeostasis-related genes could be involved in the decrease of mtDNA copy number in systemic lupus erythematosus patientsGiada De Benedittis, Andrea Latini, Chiara Morgante, et al.
Pageof 20